Dr. Jack Burks By Dr. Jack Burks MSAA’s Chief Medical Consultant Q: If someone has lesions on his or her spine, can Tysabri possibly help with relapsing-remitting MS? I have […]
Read News ArticleAuthor: Hoff Communications
The Motivator – Winter/Spring 2018
View/Download PDF View Digital Edition Cover Story Finding Direction When Newly Diagnosed By Susan Wells Courtney Topics include MS basics, treatment options, details on symptoms, relationships, employment issues, SSDI, and […]
Read News ArticleUp Front: Accepting the “New Normal” for Life with Multiple Sclerosis
Gina Ross Murdoch By Gina Ross Murdoch MSAA President and CEO You hear the news, “You have multiple sclerosis,” and wonder what is next and how you will handle this […]
Read News ArticleProgram Notes: Spring Forward, Cool Ahead
By Peter Damiri Vice President of Programs and Services Spring Forward, Cool Ahead As we welcome the start of spring and look forward to nicer weather, this is a perfect […]
Read News ArticleStories to Inspire: Finding Happiness after an MS Diagnosis
By Courtney Carver Courtney Carver making notes while enjoying the outdoors. The author found happiness by removing the overwhelming stress and clutter from her life. Following her diagnosis, Courtney simplified […]
Read News Article
Volunteer with MSAA
Street Squad members work to spread the word about MSAA, MS, and Swim for MS fundraiser to raise awareness about multiple sclerosis. This can be done through social media or by visiting local businesses.
Read News ArticleFDA Helping with Zinbryta® Withdrawal
As a follow-up to MSAA’s online article, “Zinbryta® Withdrawn from Marketplace,” MSAA is alerting individuals taking Zinbryta® (daclizumab) to additional information on the withdrawal. On March 14, 2018, the United […]
Read News ArticleHelpful Tools for MS Relapse Management
In this archived webinar, neurologist Dr. Elizabeth Crabtree defines an MS relapse or exacerbation versus a pseudoexacerbation, describes the risk factors for relapses, and offers treatment options and preventative strategies. […]
Read News ArticleZinbryta® Withdrawn from Marketplace
On March 2, 2018, Biogen and AbbVie announced the voluntary withdrawal of their MS medication, Zinbryta® (daclizumab), due to new safety concerns. Eight cases of inflammatory encephalitis and meningoencephalitis – […]
Read News Article